Position in RVMD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$57,906,976
New position
Shares Held
309,200
first reported quarter
Ownership
0.144%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#80
of 685 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 20261832 Asset Management L.P. holds $312,434,848 across 9 Biotechnology names. RVMD ranks #2 (18.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
157,940 | $146,531,993 | |
| 2 | RVMD |
Revolution Medicines, Inc.
This page
|
309,200 | $57,906,976 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
538,500 | $43,893,135 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
99,300 | $36,906,831 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
186,300 | $10,235,322 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
28,000 | $6,853,560 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
88,100 | $5,004,961 | |
| 8 | INCY |
Incyte Corp
|
42,067 | $4,768,715 |
All Filings in RVMD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,906,976 | 309,200 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||